134,063 stocks of the shares were exchanged. the share has a valuation of $14.17 B, a PE book ratio of 99.58 along with a stock beta of -0.03. the company has 50 Day SMA of $72.65 and a two hundred SMA of $69.09.
AllianceBernstein Holding L.P.is engaged in providing research, investment management and related services to a range of clients through its three buy-side distribution channels: Institutions, Retail and Private Wealth Management, and its sell-side business, Bernstein Research Services. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Van Eck Associates Corp increased Franco (FNV) stake by 17.36% reported in 2016Q4 SEC filing. About 585,263 shares traded or 5.42% up from the average. It has underperformed by 4.19% the S&P500.
Franco-Nevada Corporation (FNV) stock price moved Upswing along with the volume 1.01 million shares in Wednesday session. Therefore 50% are positive. TD Securities boosted their price target on Franco-Nevada Corporation from $83.00 to $88.00 and gave the company a "buy" rating in a research note on Thursday. The firm has "Hold" rating given on Friday, December 11 by Deutsche Bank. The rating was upgraded by SunTrust to "Buy" on Tuesday, October 18. Citigroup maintained AllianceBernstein Holding LP (NYSE:AB) on Friday, July 29 with "Buy" rating. Barclays PLC reissued an "equal weight" rating and issued a $74.00 price objective (up from $68.00) on shares of Franco-Nevada Corporation in a research report on Tuesday, June 6th. The stock has "Neutral" rating by Goldman Sachs on Thursday, February 9. Clarkson Capital initiated the shares of FNV in report on Tuesday, February 16 with "Buy" rating. The rating was downgraded by UBS on Monday, March 28 to "Neutral".
First Eagle Investment Management Llc decreased Cincinnati Finl Corp (NASDAQ:CINF) stake by 60,650 shares to 2.80 million valued at $211.93M in 2016Q4. Cibc World Markets Inc. added to its ownership by buying 2,540,547 shares an increase of 10,203.0% as of 06/30/2017. Salix Pharmaceuticals Inc (NYSE:SLB) was reduced too. The Firm offers a range of investment services, including equity strategies, with global and regional portfolios across capitalization ranges and investment strategies, including value, growth and equities; traditional and unconstrained fixed income strategies, including taxable and tax-exempt strategies; passive management, including index and enhanced index strategies; alternative investments, including hedge funds, fund of funds and private equity, and multi-asset solutions and services, including dynamic asset allocation, customized target-date funds and target-risk funds. New investors can be tempted to try to maximize returns by owning one specific sector or be exposed to a fairly large single investment. The NYSE listed company saw a recent bid of $44.42 and 558474 shares have traded hands in the session. The Virginia-based Wilbanks Smith & Thomas Asset Management Llc has invested 0.29% in the stock. The number of shares now owned by investors are 156.68 mln.
Ratings analysis reveals 43% of Humana's analysts are positive.
Among 4 analysts covering Anglogold Ashanti Limited (NYSE:AU), 2 have Buy rating, 1 Sell and 1 Hold. Aclaris Therapeutics has $54 highest and $20 lowest target. The stock's average target of $214.33 is -14.86% below today's ($251.75) share price. SCHW was included in 6 notes of analysts from September 26, 2016. The company was maintained on Thursday, October 13 by RBC Capital Markets.
05/12/2016 - Franco-Nevada Corporation was downgraded to "market perform" by analysts at BMO Capital Markets.
In other news, insider Jason O'connell sold 15,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 17th.
01/13/2017 - Franco-Nevada Corporation was upgraded to "outperform" by analysts at Credit Suisse. The rating was upgraded by JP Morgan on Thursday, November 10 to "Overweight".
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.